The delicate strands that carry life's genetic code take a beating as they jumble about in the course of their work. If left untreated, errors accumulate, with fatal consequences for the organism. This is where two key proteins come to the rescue: PARP acts as a marker for a trouble spot, allowing XRCC1 to zoom in and begin a repair.
This survey study among women with breast cancer in Mexico evaluates their specific concerns about and high hesitancy rate toward COVID-19 vaccination.
Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian investigators. The study findings may have implications for developing better risk assessment tools for TNBC in African-American women and for understanding why they have poorer TNBC outcomes.
Scientists studying the link between cholesterol and breast cancer report that a byproduct of cholesterol metabolism causes some cells to send out cancer-promoting signals to other cells. These signals are packaged in membrane-bound compartments called extracellular vesicles.
'Hepatocellular carcinoma (HCC) is the third leading cause of cancer related death worldwide, with a poor median survival time after diagnosis of six months.'
A new study of more than 350,000 women found that women with diets incorporating more foods that increase inflammation in the body had a 12% increase in their risk of breast cancer compared to women who consume more anti-inflammatory diets. The new findings are being presented at NUTRITION 2021 LIVE ONLINE.
A new treatment with potential to improve the outcomes for patients with hereditary BRCA mutations and high-risk, early-stage breast cancer appeared June 3 in the New England Journal of Medicine and will be presented June 6 at the 2021 ASCO Annual Meeting. These results represent the first time a PARP inhibitor has been shown to significantly reduce the risk of breast cancer returning in high-risk patients following completion of standard chemotherapy, surgery and radiation therapy.
Interdisciplinary team finds combining certain data after a patient's first treatment can predict how a tumor will respond to chemotherapy.
Nearly three-quarters of breast cancer patients (73%) report using at least one type of complementary medicine after cancer diagnosis, while oncologists believe that less than half (43%) of patients are using these approaches during cancer care. These and other findings from a national survey of oncologists and breast cancer patients were released in conjunction with the 2021 ASCO Annual Meeting. The study found that doctors report discussing integrative health with only about half of patients, leading patients to seek information outside the clinic.
New research shows that diet, including fish oil supplements, can alter not only the breast microbiome, but also breast cancer tumors. The study appears online in Cancer Research, a journal of the American Association for Cancer Research.